Sensex Today | Stock Market Close on Tuesday, December 30, 2025: In the broader markets, the Nifty Midcap 100 and Nifty Smallcap 100 ended lower by 0.15 per cent and 0.28 per cent, respectively
Around 70 per cent of the 102 firms that went public this year finished their first trading session in positive territory, data showed
IPO Calendar: The SME segment will see robust activity, with several new issues lined up, including EPW India, Dachepalli Publishers, Shyam Dhani Industries, Sundrex Oil Co, and Dhara Rail Projects
Gujarat Kidney IPO will be offered at a price band of ₹108 to ₹114 per share, with a lot size of 128 shares
From record fundraising and landmark listings to high-stakes corporate splits, global tech partnerships and boardroom disputes, here's how 2025 reshaped India's corporate landscape
Upcoming IPO Calendar: Corona Remedies and Wakefit Innovations are set to debut on Friday, December 15, followed by Nephrocare Health and Park Medi World, both scheduled to list on Sunday, December 17
The ₹10,602.65-crore IPO is a pure Offer for Sale (OFS), with Prudential Corporation Holdings offloading up to 49 million (48,972,994) equity shares, as detailed in the Red Herring Prospectus (RHP)
ICICI Prudential AMC IPO: Analysts at Canara Bank Securities and Anand Rathi have recommended subscribing to the issue from a long-term perspective
KSH International aims to raise ₹710 crore through a combination of fresh issue of 10.9 million shares worth up to ₹420 crore and OFS of 7.6 million shares worth up to ₹290 crore
Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares
Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5
Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12
Sensex Today | Stock Market close, December 03, 2025: In the broader markets, Nifty MidCap and Nifty SmallCap, fell 0.98 per cent and 0.71 per cent, respectively.
Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares
data on 189 IPOs where information is available show that the total amount to be raised through fresh equity was Rs 1.20 trillion, with another offer for sale (OFS) component being Rs 62,000 crore
Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.
Vidya Wires IPO will open for subscription on Wednesday, December 3, 2025, and close on Friday, December 5, 2025
Aequs aims to raise ₹921.81 crore through a combination of fresh issue of 54 million shares worth ₹670 crore and an offer for sale of 20.3 million shares worth ₹251.81 crore
Meesho aims to raise ₹4,250 crore through the fresh issue, and public shareholders will be selling 105.5 million equity shares through an offer-for-sale
Meesho IPO comprises a combination of fresh issue of ₹4,250 crore and an offer for sale (OFS) of 175.7 million equity shares